Form 8-K - Current report:
SEC Accession No. 0001096906-23-000961
Filing Date
2023-05-03
Accepted
2023-05-03 10:34:58
Documents
13
Period of Report
2023-04-25
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 MYCOTOPIA THERAPIES, INC. - FORM 8-K SEC FILING tpia-20230425.htm   iXBRL 8-K 20091
  Complete submission text file 0001096906-23-000961.txt   151791

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tpia-20230425_def.xml EX-101.DEF 1809
3 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT tpia-20230425_lab.xml EX-101.LAB 20867
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tpia-20230425_pre.xml EX-101.PRE 13875
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tpia-20230425.xsd EX-101.SCH 2349
7 EXTRACTED XBRL INSTANCE DOCUMENT tpia-20230425_htm.xml XML 2429
Mailing Address 480 22ND STREET HEYBURN ID 83336
Business Address 480 22ND STREET HEYBURN ID 83336 208-677-2020
Mycotopia Therapies, Inc. (Filer) CIK: 0001763329 (see all company filings)

EIN.: 870645794 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56022 | Film No.: 23882218
SIC: 2833 Medicinal Chemicals & Botanical Products